ArticlePloS one2025
Quality assessment of medicinal material Daqingye and Banlangen from Isatis tinctoria Fort. reveals widespread substitution with Strobilanthes species.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIsatidis Folium (Daqingye, DQY) and Isatidis Radix (Banlangen, BLG) are the leaf and root of the plant Isatis tinctoria Fort. (syn. Isatis indigotica Fort.), commonly prescribed for detoxification, and the inhibition of viral and oxidative activities. Given their widespread use, we set forth to investigate the authenticity and chemical composition of DQY and BLG samples obtained from eighteen administrative districts in the Hong Kong market.
methodsThe present study screened the identities and chemical composition of DQY and BLG through molecular authentication and HPLC methods, respectively. Molecular authentication utilized DNA barcoding, focusing on nuclear ribosomal and chloroplast regions. The HPLC methods were conducted in accordance with the Hong Kong Chinese Materia Medica Standards (HKCMMS).
resultsWe found that only one sample was genuine according to the species definition in the Chinese Pharmacopoeia and HKCMMS for both herbs. The chemical composition of the adulterated and the genuine samples were completely different, that the adulterant samples did not have the standard chemical markers epigoitrin and indirubin of Banlangen and Daqingye as listed in the Chinese Pharmacopoeia.
conclusionOur investigation underscores the widespread substitution by Strobilanthes (Nanbanlangen and Nandaqingye) species, mainly due to the preference of use of this herb in southern China. The adulteration of Daqingye by Blumea balsamifera (Ainaxiang) was probably due to mislabeling in the herb shop, though the error might have originated from the supplying sources. We recommend providing education on the necessity of using authentic Daqingye and Banlangen, especially in combined regimens, to standardize treatment effects. More education is also needed on the morphological differentiation of Banlangen from Nanbanlangen and Daqingye from Nandaqingye. The implementation of a track-and-trace system is strongly recommended to prevent and deter incorrect supply chain practices that lead to substitution or adulteration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.